EHNA
Identifiers | |
---|---|
| |
CAS Number | 59262-86-1 |
PubChem (CID) | 3206 |
ChemSpider | 3094 |
ChEMBL | CHEMBL50378 |
Chemical and physical data | |
Formula | C14H24N5O |
Molar mass | 313.826 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
EHNA (erythro-9-(2-hydroxy-3-nonyl)adenine) is a potent adenosine deaminase inhibitor,[1] which also acts as a phosphodiesterase inhibitor that selectively inhibits phosphodiesterase type 2 (PDE2).[2][3]
References
- ↑ "Sigma Aldrich". Retrieved 16 January 2013.
- ↑ Podzuweit, T; Nennstiel, P; Muller, A (1995). "Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine". Cell Signal. 7 (7): 733–8. doi:10.1016/0898-6568(95)00042-N. PMID 8519602.
- ↑ Méry, PF; Pavoine, C; Pecker, F; Fischmeister, R (1995). "Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes". Mol Pharmacol. 48 (1): 121–130. PMID 7623766.
This article is issued from Wikipedia - version of the 6/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.